won’t have thought so, it’s just talks. Once a binding material agreement for trial is signed it is subject to continuous disclosure - even if subject to CDA.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1014
-
- There are more pages in this discussion • 411 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $91.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10023 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 1400 | 1 |
View Market Depth
| Last trade - 09.41am 15/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable